The European Medical Awards is a structured healthcare recognition programme that evaluates institutions based on patient experience, clinical transparency, treatment quality and international care standards.
Evaluations are based on submitted documentation, publicly available information and defined internal criteria.
No.
The European Medical Awards is not a regulatory authority, medical certification body or accreditation institution. It does not replace national healthcare regulation, licensing or formal clinical accreditation.
Recognition reflects alignment with the programme’s internal evaluation criteria only.
Institutions may be considered through direct application or through a limited, selection-based invitation process.
Invited institutions are identified based on publicly available information and initial internal review.
By default, one award is granted per institution.
A maximum of two awards may be allocated in cases where strong performance is demonstrated across multiple distinct categories.
Institutions must achieve a minimum score of 75/100 within the weighted evaluation framework.
Only institutions meeting or exceeding this threshold are eligible for recognition.
The evaluation may include submitted documentation, publicly available patient feedback and reputation signals, treatment structure and communication processes, and observable service consistency.
Additional information may be requested where necessary.
Yes.
Only institutions that submit the required documentation via email can be fully evaluated.
Incomplete submissions may not be considered.
No.
Recognition cannot be purchased. Payment, sponsorship or advertising has no influence on evaluation outcomes.
No.
Documents may be submitted in any language. Non-English materials may be reviewed using automated translation tools.
The European Medical Awards is not responsible for inaccuracies resulting from automated translation.
Applicants may provide certified translations if preferred.
No.
The programme does not conduct on-site inspections, clinical audits or direct medical assessments.
All evaluations are based on submitted materials and available external information.
Applications for the 2026 cycle must be submitted by 31 October 2026 at 23:59 CET.
Applications will be evaluated during November, and final decisions will be communicated by 30 November 2026.
Initial eligibility and completeness screening normally begins after submission.
Full category evaluations for the 2026 cycle will be completed during November 2026.
Final decisions will be communicated by 30 November 2026.
Additional clarification may be requested during the review period.
No.
Submission does not guarantee recognition. All applications are evaluated against defined criteria, and the number of recognitions is intentionally limited.
